These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38477436)

  • 1. Unusual Head Drops, Neck and Truncal Dystonia and Sleep Orthopnea with a Favorable Treatment Response in IgLon5 Antibody Disease.
    Bavdhankar K; Jain N; Agrawal S; Maheshkar P; Andugulapati SS; Puntambekar S; Ravat SH; Agarwal PA
    Mov Disord Clin Pract; 2024 May; 11(5):575-577. PubMed ID: 38477436
    [No Abstract]   [Full Text] [Related]  

  • 2. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies.
    Brüggemann N; Wandinger KP; Gaig C; Sprenger A; Junghanns K; Helmchen C; Münchau A
    Mov Disord; 2016 May; 31(5):762-4. PubMed ID: 27030137
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.
    Gaig C; Ercilla G; Daura X; Ezquerra M; Fernández-Santiago R; Palou E; Sabater L; Höftberger R; Heidbreder A; Högl B; Iranzo A; Santamaria J; Dalmau J; Graus F
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Clinical Spectrum of IgLON5-Syndrome.
    Wenninger S
    J Neuromuscul Dis; 2017; 4(4):337-339. PubMed ID: 29103046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons.
    Ryding M; Gamre M; Nissen MS; Nilsson AC; Okarmus J; Poulsen AAE; Meyer M; Blaabjerg M
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.
    Erro ME; Sabater L; Martínez L; Herrera M; Ostolaza A; García de Gurtubay I; Tuñón T; Graus F; Gelpi E
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.
    Sabater L; Planagumà J; Dalmau J; Graus F
    J Neuroinflammation; 2016 Sep; 13(1):226. PubMed ID: 27586161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy.
    Cagnin A; Mariotto S; Fiorini M; Gaule M; Bonetto N; Tagliapietra M; Buratti E; Zanusso G; Ferrari S; Monaco S
    J Alzheimers Dis; 2017; 59(1):13-20. PubMed ID: 28550263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
    Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
    Front Immunol; 2021; 12():753856. PubMed ID: 34659261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New knowledge on anti-IgLON5 disease.
    Gaig C; Sabater L
    Curr Opin Neurol; 2024 Jun; 37(3):316-321. PubMed ID: 38563128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Presentation of the Acute Airway: Anti-IgLON5 Disease.
    Chen J; Vasani S
    Laryngoscope; 2021 Mar; 131(3):E724-E726. PubMed ID: 32750166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.
    Landa J; Gaig C; Plagumà J; Saiz A; Antonell A; Sanchez-Valle R; Dalmau J; Graus F; Sabater L
    Ann Neurol; 2020 Nov; 88(5):1023-1027. PubMed ID: 32740999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epileptic seizures in patients with anti-IgLON5 disease.
    Wang Y; Wang Y; Zhao X; Zhang S; Geng Y; Zhang Z; Jin B; Aung T
    J Neuroimmunol; 2022 Dec; 373():577999. PubMed ID: 36395637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome.
    Werner J; Jelcic I; Schwarz EI; Probst-Müller E; Nilsson J; Schwizer B; Bloch KE; Lutterotti A; Jung HH; Schreiner B
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological criteria of anti-IgLON5-related tauopathy.
    Gelpi E; Höftberger R; Graus F; Ling H; Holton JL; Dawson T; Popovic M; Pretnar-Oblak J; Högl B; Schmutzhard E; Poewe W; Ricken G; Santamaria J; Dalmau J; Budka H; Revesz T; Kovacs GG
    Acta Neuropathol; 2016 Oct; 132(4):531-43. PubMed ID: 27358064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autopsy case of MM2-thalamic subtype of sporadic Creutzfeldt-Jakob disease with Lewy bodies presenting as a sleep disorder mimicking anti-IgLON5 disease.
    Hongo Y; Iizuka T; Kaneko A; Suga H; Uchino A; Murayama S; Namba K; Inoue Y; Nishiyama K
    J Neurol Sci; 2019 Sep; 404():36-39. PubMed ID: 31325665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.